A novel EGFR inhibitor HNPMI regulates apoptosis and oncogenesis by modulating BCL2BAX and p53 in colon cancer

Simple item page
dc.article.end-page124en
dc.article.start-page107en
dc.citation.doi10.1111/BPH.16141en
dc.contributor.authorJeyalakshmi Kandhaveluen
dc.contributor.authorKumar Subramanianen
dc.contributor.authorVivash Naidooen
dc.contributor.authorG Sebastianellien
dc.contributor.authorP Doanen
dc.contributor.authorS K Manien
dc.contributor.authorH Yapislaren
dc.contributor.authorE et alen
dc.contributor.authorClement Pennyen
dc.date.accessioned2024-10-08T09:26:19Z
dc.date.available2024-10-08T09:26:19Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn0007-1188en
dc.identifier.urihttps://hdl.handle.net/10539/41438
dc.journal.titleA novel EGFR inhibitor HNPMI regulates apoptosis and oncogenesis by modulating BCL2BAX and p53 in colon canceren
dc.journal.volume181en
dc.publisherWILEY-BLACKWELLen
dc.titleA novel EGFR inhibitor HNPMI regulates apoptosis and oncogenesis by modulating BCL2BAX and p53 in colon canceren
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
3.83 MB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download

Collections

Academic Wits Research Outputs (All submissions)